Chronic News and Research

RSS

Shifts in patient and physician trends shape primary care in Alberta

In this study, researchers examined changes over time in characteristics of adults cared for by family physicians from 2004 to 2020 in Alberta, Canada, along with trends in family physicians and their practice patterns for adults over 18 years old.

23 Sep 2025

Orforglipron pill improves heart and metabolic risk factors in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

22 Sep 2025

The short shelf-life of truth: Debunking meat myths doesn’t last

Researchers tested the “truth sandwich” technique on German meat consumers and found it effectively reduced belief in common meat myths immediately after exposure. However, the corrective effects disappeared within two weeks, showing that lasting change needs repeated interventions.

22 Sep 2025

Gut microbial imbalance linked to chronic sickle cell disease pain

A research collaboration involving scientists and students at The University of Texas at Dallas has found a clear connection between chronic sickle cell disease pain and the bacteria present in the gastrointestinal tract.

22 Sep 2025

Scientists use blood chemistry to predict disease years before it strikes

Researchers built the largest plasma metabolome-phenome atlas using 274,241 UK Biobank participants, linking over 73,000 metabolite-trait and 52,000 metabolite-disease associations. The study shows metabolic risk scores can predict diseases years before diagnosis, with strong accuracy for diabetes and kidney complications.

22 Sep 2025

New molecular signatures map the stepwise development of gastric cancer

Gastric cancer often develops through a gradual sequence of changes, beginning with superficial gastritis and advancing through chronic atrophic gastritis, intestinal metaplasia, and precancerous lesions before culminating in malignancy.

22 Sep 2025

Psychological distress after a heart attack emerges as a critical risk factor for heart health

Many people experience one or more types of psychological distress, including depression, anxiety, psychosocial stress or post-traumatic stress disorder (PTSD), after a heart attack, which can affect their physical recovery and long-term heart health, according to a new American Heart Association scientific statement, published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

22 Sep 2025

Lysosomal acidity fine-tunes reactive species production in macrophages

Macrophages rely on lysosomes to balance microbial killing with self-protection, generating reactive oxygen and nitrogen species during phagocytosis.

21 Sep 2025

Childhood exposure to plastic chemicals linked to long-term health risks

Childhood exposure to chemicals used to make plastic household items presents growing health risks that can extend long into adulthood, experts from NYU Langone Health report.

21 Sep 2025

Coffee protects the liver by blocking inflammation and scarring, review finds

A new review in Biochemical Pharmacology synthesizes decades of research showing consistent links between regular coffee consumption and reduced risk of liver disease, including cirrhosis and liver cancer. Coffee’s bioactive compounds act on antioxidant, anti-inflammatory, antifibrotic, and metabolic pathways to slow liver damage progression.

21 Sep 2025

Hurricane Sandy survivors face elevated heart risks long after the storm

Researchers studying Medicare beneficiaries found that Hurricane Sandy–related flooding modestly increased cardiovascular disease risk for up to five years. Heart failure drove much of the rise, particularly in New Jersey, with short-term and delayed spikes observed.

21 Sep 2025

Inhaling marijuana associated with increased odds of developing asthma

If you're looking to reduce your chances of developing lung disease, say experts at UC San Francisco, then it may be smart to avoid inhaling cannabis.

19 Sep 2025

Survey reveals why some people turn to unregulated cannabis to treat medical conditions

Use of medical cannabis has been on the rise since it first became available to Utah patients in 2020. A medical cannabis card, which can be prescribed for difficult-to-treat conditions including PTSD and chronic pain, allows a patient to access licensed cannabis products in designated pharmacies.

19 Sep 2025

WHO's new report highlights the urgent need to address NCDs and mental health

The World Health Organization (WHO) today released a new report titled "Saving lives, spending less", revealing that an additional investment of just US$3 per person annually in tackling noncommunicable diseases (NCDs) could yield economic benefits of up to US$1 trillion by 2030.

19 Sep 2025

$Kennedy’s take on vaccine science fractures cohesive national public health strategies$

Kennedy’s take on vaccine science fractures cohesive national public health strategies

Health and Human Services Secretary Robert F. Kennedy Jr. has had a busy few months. He fired the director of the Centers for Disease Control and Prevention, purged the agency's vaccine advisory committee, and included among the group's new members appointees who espouse anti-vaccine views.

19 Sep 2025

Exactech will pay $8M to settle lawsuits over defective knee implant parts

19 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

Verapamil shows potential for preserving beta-cell function in type 1 diabetes

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.

18 Sep 2025

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions

18 Sep 2025

Study reveals early nicotinamide use reduces risk of aggressive skin cancers

A large U.S. Department of Veterans Affairs cohort study found that Nicotinamide use was associated with a 14% lower risk of new keratinocyte skin cancers, driven by a 22% reduction in cSCC and no reduction in BCC. The strongest benefit (56% lower risk) appeared when nicotinamide was started after a patient’s first skin cancer, with diminishing returns after multiple cancers.

18 Sep 2025